Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Mark Eckardt

Concepts (220)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
10
2026
207
1.900
 Why?
Liposarcoma
4
2023
31
1.210
 Why?
Soft Tissue Neoplasms
4
2025
131
1.110
 Why?
Psoriasis
2
2024
115
0.900
 Why?
Mindfulness
2
2024
136
0.830
 Why?
Doxorubicin
9
2018
401
0.760
 Why?
Retroperitoneal Neoplasms
1
2022
28
0.750
 Why?
Carbon-Sulfur Lyases
6
2018
14
0.720
 Why?
Xenograft Model Antitumor Assays
9
2018
934
0.630
 Why?
Referral and Consultation
1
2025
867
0.580
 Why?
Salmonella typhimurium
5
2018
188
0.510
 Why?
Antimetabolites, Antineoplastic
2
2018
106
0.400
 Why?
Radiodermatitis
1
2013
11
0.380
 Why?
Deoxycytidine
2
2018
220
0.380
 Why?
Compartment Syndromes
1
2013
36
0.370
 Why?
Philadelphia Chromosome
1
2011
18
0.350
 Why?
Sarcoma, Ewing
3
2018
103
0.350
 Why?
Chromosomes, Human, Pair 19
1
2011
27
0.350
 Why?
Blast Crisis
1
2011
34
0.350
 Why?
Hemangioendothelioma, Epithelioid
1
2011
7
0.350
 Why?
Chromosomes, Human, Pair 1
1
2011
80
0.340
 Why?
Drug Resistance, Neoplasm
6
2018
881
0.340
 Why?
Thiazoles
1
2011
141
0.330
 Why?
Mice, Nude
11
2018
679
0.330
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2011
127
0.320
 Why?
Pyrimidines
3
2018
530
0.320
 Why?
Nerve Sheath Neoplasms
2
2019
13
0.300
 Why?
Recombinant Proteins
5
2018
1368
0.300
 Why?
Image-Guided Biopsy
2
2019
41
0.250
 Why?
Melanoma
3
2018
759
0.250
 Why?
Bone Matrix
2
2018
6
0.250
 Why?
Neoplasm Recurrence, Local
4
2022
1149
0.230
 Why?
Sphincterotomy, Transduodenal
1
2025
2
0.230
 Why?
Piperazines
3
2018
375
0.220
 Why?
Extremities
1
2026
141
0.220
 Why?
Ampulla of Vater
1
2025
40
0.220
 Why?
Cyclin-Dependent Kinase 4
2
2016
53
0.210
 Why?
Lumbar Vertebrae
2
2018
252
0.210
 Why?
Cyclin-Dependent Kinase 6
2
2016
49
0.210
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2019
1963
0.200
 Why?
Pyridines
3
2018
609
0.200
 Why?
Gastric Bypass
1
2025
126
0.200
 Why?
Spinal Fusion
2
2018
262
0.190
 Why?
Lipoma
1
2023
17
0.190
 Why?
Humans
35
2026
145474
0.190
 Why?
Retrospective Studies
10
2026
17291
0.190
 Why?
Robotic Surgical Procedures
1
2025
185
0.180
 Why?
Bone Marrow Transplantation
2
2015
298
0.180
 Why?
Microsatellite Instability
1
2022
55
0.180
 Why?
Bone Neoplasms
2
2016
259
0.170
 Why?
Antineoplastic Agents
3
2018
2214
0.170
 Why?
Salmonella Infections
2
2018
57
0.170
 Why?
Positron Emission Tomography Computed Tomography
1
2021
117
0.160
 Why?
Gastrointestinal Stromal Tumors
1
2021
41
0.160
 Why?
Adolescent
8
2025
22529
0.160
 Why?
Biopsy, Large-Core Needle
1
2019
15
0.150
 Why?
Self Report
1
2024
870
0.150
 Why?
Colorectal Neoplasms
2
2022
866
0.150
 Why?
Neoadjuvant Therapy
2
2020
465
0.150
 Why?
Cisplatin
2
2018
345
0.150
 Why?
Proto-Oncogene Proteins B-raf
2
2018
223
0.150
 Why?
Lipopolysaccharides
1
2022
858
0.150
 Why?
Fibrosarcoma
1
2018
23
0.140
 Why?
Prognosis
6
2026
4316
0.140
 Why?
Aged
11
2026
26153
0.140
 Why?
Bone Demineralization Technique
1
2018
1
0.140
 Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2018
53
0.130
 Why?
Furans
1
2017
26
0.130
 Why?
Pseudomonas putida
1
2018
44
0.130
 Why?
Osteosarcoma
1
2018
82
0.130
 Why?
Ketones
1
2017
50
0.130
 Why?
Female
17
2026
78844
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2016
15
0.120
 Why?
RNA-Binding Protein FUS
1
2016
13
0.120
 Why?
Combined Modality Therapy
3
2018
1266
0.120
 Why?
Cell Tracking
1
2016
18
0.120
 Why?
Receptor, IGF Type 1
1
2016
64
0.120
 Why?
Tumor Microenvironment
1
2021
734
0.120
 Why?
Bone Marrow
1
2018
306
0.120
 Why?
Middle Aged
10
2026
36215
0.120
 Why?
Male
16
2026
72842
0.120
 Why?
Immunotherapy
1
2021
666
0.110
 Why?
Neoplasms, Experimental
1
2016
167
0.110
 Why?
Luminescent Proteins
1
2016
186
0.110
 Why?
Bone Transplantation
1
2015
88
0.110
 Why?
Oncogene Proteins, Fusion
1
2016
212
0.100
 Why?
Postoperative Complications
2
2025
2970
0.100
 Why?
Depression
1
2024
1546
0.100
 Why?
Body Weight
4
2018
971
0.100
 Why?
Precision Medicine
1
2018
459
0.100
 Why?
Aurora Kinase A
1
2013
61
0.100
 Why?
Molecular Targeted Therapy
1
2016
439
0.100
 Why?
Sarcoma, Synovial
1
2013
20
0.100
 Why?
Random Allocation
3
2018
365
0.100
 Why?
Prospective Studies
2
2022
8057
0.100
 Why?
Young Adult
4
2025
14218
0.100
 Why?
Musculoskeletal Diseases
1
2014
90
0.100
 Why?
Phthalazines
1
2013
63
0.090
 Why?
Adult
8
2026
40777
0.090
 Why?
Tumor Burden
3
2018
325
0.090
 Why?
T-Lymphocytes
1
2021
1996
0.090
 Why?
Curettage
1
2012
8
0.090
 Why?
Giant Cell Tumor of Bone
1
2012
8
0.090
 Why?
Animals
13
2018
38030
0.090
 Why?
Dasatinib
1
2011
58
0.090
 Why?
Surveys and Questionnaires
1
2024
6066
0.080
 Why?
Fatal Outcome
1
2011
305
0.080
 Why?
Tibia
1
2012
176
0.080
 Why?
Mice
8
2018
18329
0.080
 Why?
Survival Analysis
3
2019
1374
0.080
 Why?
Databases, Factual
3
2020
1490
0.070
 Why?
Tumor Suppressor Protein p53
1
2013
534
0.070
 Why?
Mutation
2
2018
4075
0.070
 Why?
Fatty Liver
1
2011
253
0.070
 Why?
Indazoles
2
2018
85
0.070
 Why?
Lung Neoplasms
2
2018
2664
0.060
 Why?
Green Fluorescent Proteins
2
2018
407
0.060
 Why?
France
1
2026
40
0.060
 Why?
Italy
1
2026
116
0.060
 Why?
Tumor Cells, Cultured
2
2018
886
0.060
 Why?
Administration, Oral
2
2018
866
0.060
 Why?
Liver Neoplasms
1
2011
776
0.050
 Why?
Constriction, Pathologic
1
2025
249
0.050
 Why?
Sulfonamides
2
2018
583
0.050
 Why?
Bayes Theorem
1
2026
420
0.050
 Why?
Cell Proliferation
3
2018
2507
0.050
 Why?
Mitotic Index
1
2023
25
0.050
 Why?
Disease Models, Animal
3
2018
4560
0.050
 Why?
Drug Screening Assays, Antitumor
2
2013
194
0.050
 Why?
Neoplasms
1
2018
2906
0.050
 Why?
Treatment Outcome
4
2018
11772
0.040
 Why?
Mitosis
1
2023
193
0.040
 Why?
DNA Mismatch Repair
1
2022
53
0.040
 Why?
Neoplasm Staging
2
2019
1471
0.040
 Why?
Imatinib Mesylate
1
2021
77
0.040
 Why?
Fluorodeoxyglucose F18
1
2021
161
0.040
 Why?
Radiopharmaceuticals
1
2021
205
0.040
 Why?
Cell Cycle
2
2013
598
0.040
 Why?
Germany
1
2020
138
0.040
 Why?
Neurofibroma
1
2019
5
0.040
 Why?
Positron-Emission Tomography
1
2021
343
0.040
 Why?
Neurilemmoma
1
2019
25
0.040
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
153
0.040
 Why?
Risk Assessment
2
2019
3747
0.040
 Why?
Hospitals, High-Volume
1
2019
50
0.040
 Why?
Age Factors
2
2018
3342
0.040
 Why?
Chemotherapy, Adjuvant
1
2020
423
0.040
 Why?
Magnetic Resonance Imaging
1
2011
3904
0.040
 Why?
Cohort Studies
2
2019
6013
0.030
 Why?
S Phase Cell Cycle Checkpoints
1
2018
4
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.030
 Why?
Empathy
1
2020
181
0.030
 Why?
Gene Amplification
1
2018
118
0.030
 Why?
Suction
1
2018
32
0.030
 Why?
Transplantation, Heterologous
1
2018
170
0.030
 Why?
Taxoids
1
2018
114
0.030
 Why?
Injections, Intraperitoneal
1
2017
116
0.030
 Why?
Heterografts
1
2018
143
0.030
 Why?
Point Mutation
1
2018
240
0.030
 Why?
California
1
2019
471
0.030
 Why?
Neoplasm Invasiveness
1
2019
506
0.030
 Why?
Disease-Free Survival
1
2019
767
0.030
 Why?
Artificial Intelligence
1
2022
381
0.030
 Why?
Administration, Intravenous
1
2017
172
0.030
 Why?
Early Detection of Cancer
1
2022
485
0.030
 Why?
Kaplan-Meier Estimate
1
2019
969
0.030
 Why?
Orthopedic Procedures
1
2019
244
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2016
72
0.030
 Why?
Academic Medical Centers
1
2019
554
0.030
 Why?
Pyrazines
1
2016
94
0.030
 Why?
Proportional Hazards Models
1
2019
1327
0.030
 Why?
Ilium
1
2015
31
0.030
 Why?
Drug Administration Schedule
1
2017
782
0.030
 Why?
Cell Line, Tumor
2
2013
3542
0.030
 Why?
Multivariate Analysis
1
2019
1547
0.030
 Why?
Diagnosis, Differential
1
2019
1508
0.030
 Why?
Drug Therapy, Combination
1
2018
1044
0.030
 Why?
Imidazoles
1
2016
247
0.030
 Why?
Drug Delivery Systems
1
2018
381
0.030
 Why?
Apoptosis
2
2013
2440
0.030
 Why?
Reoperation
1
2018
633
0.030
 Why?
Sensitivity and Specificity
1
2019
1997
0.030
 Why?
Allografts
1
2015
152
0.030
 Why?
Transplantation, Autologous
1
2015
300
0.030
 Why?
Transplantation, Homologous
1
2015
418
0.030
 Why?
Aurora Kinase C
1
2013
2
0.030
 Why?
Aurora Kinase B
1
2013
10
0.030
 Why?
Biopsy, Needle
1
2014
185
0.030
 Why?
Retinoblastoma Protein
1
2013
60
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2013
105
0.020
 Why?
DNA Copy Number Variations
1
2013
184
0.020
 Why?
DNA Mutational Analysis
1
2013
407
0.020
 Why?
Femoral Neoplasms
1
2012
10
0.020
 Why?
Radius
1
2012
51
0.020
 Why?
Organoplatinum Compounds
1
2011
65
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2018
919
0.020
 Why?
Liver Function Tests
1
2011
105
0.020
 Why?
Mice, Transgenic
1
2016
2188
0.020
 Why?
Aged, 80 and over
2
2015
8333
0.020
 Why?
Carcinoma, Renal Cell
1
2013
230
0.020
 Why?
Biomarkers
1
2021
4295
0.020
 Why?
Logistic Models
1
2015
2134
0.020
 Why?
Phosphorylation
1
2013
1707
0.020
 Why?
Dose-Response Relationship, Drug
1
2013
2028
0.020
 Why?
Kidney Neoplasms
1
2013
413
0.020
 Why?
Gene Expression
1
2013
1476
0.020
 Why?
Quality of Life
1
2020
3204
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2013
1443
0.020
 Why?
Protein Kinase Inhibitors
1
2013
981
0.020
 Why?
Biomarkers, Tumor
1
2013
1321
0.010
 Why?
Sex Factors
1
2011
2105
0.010
 Why?
Follow-Up Studies
1
2014
5423
0.010
 Why?
Child
2
2014
22707
0.010
 Why?
Liver
1
2011
1896
0.010
 Why?
Body Mass Index
1
2011
2445
0.010
 Why?
United States
1
2020
16098
0.010
 Why?
Breast Neoplasms
1
2013
2382
0.010
 Why?
Infant
1
2014
10077
0.010
 Why?
Child, Preschool
1
2014
11853
0.010
 Why?
Risk Factors
1
2011
10885
0.010
 Why?
Eckardt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (220) concept(s)
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)